Serum concentration of tumor necrosis factor in patients with breast cancer

Breast Cancer Research and Treatment

Volumn 43, Issue 3, 1997, Pages 211-215

  Sheen Chen, Shyr Ming ^a   Chen, Wei Jen ^a   Eng, Hock Liew ^a   Chou, Fong Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Mastectomy; Prognosis; Serum markers; Tumor necrosis factor

Indexed keywords

ESTROGEN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE; MASTECTOMY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030905416     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005736712307     Document Type: Article

References (23)

1. Balkwill FE, Burke F: The cytokine network. Immunol Today 10: 299-304, 1989
2. Beutler B, Cerami A: Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379-385, 1987
3. Beutler B, Cerami A: Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320: 584-588, 1986
4. Sugarman BJ, Aggarwal BB, Mass PE et al.: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-949, 1985
5. Nawroth PP, Stern DM: Modulation of endothelial hemostatic properties by tumor necrosis factor. J Exp Med 163: 740-745, 1986
6. Tracey KL, Lowry SF, Fahey TJ et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986
7. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, the J5 study group, Kanbert PH: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Eng J Med 319: 397-400, 1988
8. Marano MA, Fong Y, Moldawer LL et al.: Serum cachectin/ TNF in critically ill burn patients correlates with infection and mortality. Surg Gynecol Obstet 170: 32-38, 1990
9. Palek PQ, Lin Y, Collins JL: Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms. J Immunol 138: 1641-1644, 1987
10. Balkwill F, Osborne R, Burke F et al.: Evidence for tumor necrosis factor/cachectin production in cancer. Lancet ii: 1229-1232, 1987
11. Abrahamsson J, Carlsson B, Meilander L: Tumor necrosis factor-α in malignant disease. Am J Pediatr Hematol Oncol 15: 364-369, 1993
12. Ardizzoia A, Lissoni P, Brivio F, Tisi E et al.: Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 6: 103-107, 1992
13. Sheen-Chen SM, Chou FF, Eng HL, Chen WJ: An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer. Surgery 116: 510-515, 1994
14. NIH Consensus Conference: treatment of early stage breast cancer. JAMA 265: 391-395, 1991
15. Staging for carcinoma of the breast. In: Beahrs O, Henson D, Hutter R, Myers M, (eds) Manual for staging of cancer, 3rd ed, Philadelphia: JB Lippincott, 1988, pp 145-150
16. Beutler B, Cerami A, Cachectin (Tumor Necrosis Factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocrine Reviews 9: 57-66, 1988
17. Coley WB: The treatment of malignant tumors by repeated inoculations of erysipelas; with a report often original cases. Am J Med Sci 105: 487-, 1893
18. O'Malley WE, Achinstein B, Shear MJ: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. J Natl Cancer Inst 29: 1169-, 1962
19. Beutler B, Greenwald D, Hulmes JD et al.: Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552-554, 1985
20. Feinnan R, Hernriksen-DeStefano D, Tsujimoto M, Vilcek J: Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 138: 635-640, 1987
21. Abbate I, Correale M, Gargano G et al.: Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms. Eur J Gynaec Oncol XIII Supplement N. 1, 92-96, 1992
22. Knapp ML, Al-Sheibani S, Riches PG et al.: Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem 28: 480-486, 1991
23. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761, 1992